نتائج البحث - "Simrit Parmar"

1

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

المصدر: Leukemia & Lymphoma. 61:1380-1387

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Oncology, immune system diseases, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, Mantle cell lymphoma, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fc3b8c42d34e63752f295ca82d1148a4Test
https://doi.org/10.1080/10428194.2020.1716221Test

2

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

المصدر: The Lancet Haematology. 6:e266-e275

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9048850ac063221a0cb7d2e49bcf3566Test
https://doi.org/10.1016/s2352-3026Test(19)30023-7

3

Targeting CLL-1 for acute myeloid leukemia therapy

المؤلفون: Iyer Swaminathan Padmanabhan, Hongbing Ma, Yuping Gong, Simrit Parmar

المصدر: Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Journal of Hematology & Oncology

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, CD33, Review, lcsh:RC254-282, hMICL, 03 medical and health sciences, Mice, 0302 clinical medicine, immune system diseases, Internal medicine, Cell Line, Tumor, hemic and lymphatic diseases, medicine, Animals, Humans, Lectins, C-Type, Molecular Biology, neoplasms, CD371, CD70, CLEC12A, Hematology, Acute myeloid leukemia, business.industry, lcsh:RC633-647.5, Myeloid leukemia, Hematopoietic stem cell, Immunotherapy, lcsh:Diseases of the blood and blood-forming organs, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Leukemia, Lymphocytic, Chronic, B-Cell, Disease Models, Animal, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Receptors, Mitogen, Cancer research, DCAL-2, Chimeric Antigen Receptor T-Cell Therapy, Interleukin-3 receptor, business, CLL-1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf4761df7891ca81f5a87e9a2801fb2Test
http://link.springer.com/article/10.1186/s13045-019-0726-5Test

4

Adoptive cell therapy for acute myeloid leukemia

المؤلفون: Hongbing Ma, Yuping Gong, Swaminathan P. Iyer, Simrit Parmar

المصدر: Leukemia & Lymphoma. 60:1370-1380

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, T-Lymphocytes, medicine.medical_treatment, T cell, Cell- and Tissue-Based Therapy, Receptors, Antigen, T-Cell, Cancer Vaccines, Immunotherapy, Adoptive, Donor lymphocyte infusion, Cell therapy, 03 medical and health sciences, 0302 clinical medicine, Refractory, hemic and lymphatic diseases, Internal medicine, medicine, Animals, Humans, Chemotherapy, Receptors, Chimeric Antigen, business.industry, Myeloid leukemia, Dendritic Cells, Hematology, Dendritic cell, Immunotherapy, Tissue Donors, Killer Cells, Natural, Leukemia, Myeloid, Acute, medicine.anatomical_structure, 030220 oncology & carcinogenesis, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f6f9646011d2c793eba45531bdc846Test
https://doi.org/10.1080/10428194.2018.1553300Test

5

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

المؤلفون: Rima M. Saliba, Amin M. Alousi, Uday R. Popat, Muzaffar H. Qazilbash, Simrit Parmar, Stefan O. Ciurea, Chitra Hosing, Gabriela Rondon, Mithun Vinod Shah, Partow Kebriaei, Betul Oran, Ioana Rus, Richard E. Champlin, Issa F. Khouri, Doris Soebbing, Julianne Chen

المصدر: Bone Marrow Transplant

مصطلحات موضوعية: Male, Melphalan, medicine.medical_specialty, Transplantation Conditioning, Myeloid, Cyclophosphamide, medicine.medical_treatment, Graft vs Host Disease, Pilot Projects, Hematopoietic stem cell transplantation, Mycophenolate, Gastroenterology, Tacrolimus, Article, 03 medical and health sciences, 0302 clinical medicine, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Prospective Studies, Prospective cohort study, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Mycophenolic Acid, medicine.disease, Leukemia, Myeloid, Acute, Leukemia, surgical procedures, operative, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Unrelated Donors, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453dabd1f99478f5e1b5c2608d760da8Test
https://doi.org/10.1038/s41409-018-0367-2Test

6

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

المؤلفون: Piyanuch Kongtim, Partow Kebriaei, Gheath Alatrash, Uday R. Popat, Issa F. Khouri, Richard E. Champlin, Jorge M. Ramos Perez, Denái R. Milton, Simrit Parmar, Qaiser Bashir, Gabriela Rondon, Julianne Chen, Amin M. Alousi, Abhishek Chilkulwar, Betul Oran, Borje S. Andersson, Stefan O. Ciurea, Chitra Hosing, Jin S. Im

المصدر: Bone Marrow Transplant

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Transplantation Conditioning, Myeloid, Adolescent, Concordance, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Transplantation, Homologous, Young adult, Survival rate, Aged, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Hematology, Middle Aged, Prognosis, medicine.disease, Comorbidity, Survival Rate, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, surgical procedures, operative, medicine.anatomical_structure, Myelodysplastic Syndromes, 030220 oncology & carcinogenesis, Female, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59cc90e01d7a77914f7345ddc2c1c6c9Test
https://doi.org/10.1038/s41409-018-0344-9Test

7

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

المؤلفون: Simrit Parmar, Mikaela E. Bankston, Sattva S. Neelapu, Sairah Ahmed, Jillian R. Gunther, Raphael E Steiner, Ranjit Nair, Penny Fang, Paolo Strati, Hun Ju Lee, Loretta J. Nastoupil, Bouthaina S. Dabaja, Jason R. Westin, M. Alma Rodriguez, David Boyce, Christopher R. Flowers, Swaminathan P. Iyer, Chelsea C. Pinnix, Sarah A. Milgrom

المصدر: JAMA Network Open

مصطلحات موضوعية: Adult, Male, Organs at Risk, medicine.medical_specialty, Dacarbazine, medicine.medical_treatment, Long Term Adverse Effects, Kaplan-Meier Estimate, Bleomycin, Radiation Dosage, Vinblastine, Disease-Free Survival, chemistry.chemical_compound, immune system diseases, hemic and lymphatic diseases, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, medicine, Combined Modality Therapy, Humans, Adverse effect, Original Investigation, Neoplasm Staging, Chemotherapy, Radiotherapy, business.industry, Research, Dose-Response Relationship, Radiation, General Medicine, Hodgkin Disease, Radiation therapy, Online Only, chemistry, ABVD, Oncology, Doxorubicin, Female, Radiology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e42f0a59a91ea5cb8a1860e5c01f03fTest
http://europepmc.org/articles/PMC7525355Test

8

Conditioning with Busulfan Plus Melphalan (Bu-Mel) Results in More Prolonged Progression-Free Survival (PFS) Versus Melphalan (Mel) Alone before Autologous Stem Cell Transplantation (auto-HCT) in Patients with High-Risk Multiple Myeloma (MM): Long-Term Results of a Randomized, Phase 3 Trial

المصدر: Biology of Blood and Marrow Transplantation. 26:S241-S242

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a8e14764986fcd22baae98ef1d4e988fTest
https://doi.org/10.1016/j.bbmt.2019.12.488Test

9

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

المؤلفون: Paul Lin, Krina K. Patel, Stefan O. Ciurea, Uday R. Popat, Muzaffar H. Qazilbash, Rima M. Saliba, Hossein Maymani, Samer A. Srour, Richard E. Champlin, Nina Shah, Simrit Parmar, Partow Kebriaei, Elizabeth J. Shpall, Qaiser Bashir, Borje S. Andersson, Chitra Hosing

المصدر: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 25, iss 5

مصطلحات موضوعية: Oncology, Melphalan, Male, Transplantation Conditioning, Graft vs Host Disease, Regenerative Medicine, 0302 clinical medicine, Multiple myeloma, hemic and lymphatic diseases, Cancer, Preparative Regimen, Clinical Trials as Topic, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Prognosis, Butyrophenones, Fludarabine, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, Vidarabine, medicine.drug, Homologous, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Clinical Sciences, Immunology, Article, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Humans, Transplantation, Homologous, Busulfan, Conditioning regimens, Allogeneic hematopoietic cell transplant, Aged, Retrospective Studies, Transplantation, business.industry, medicine.disease, Survival Analysis, Clinical trial, Good Health and Well Being, business, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0bf8f3c1214c2317ddf929b2f864850Test
https://pubmed.ncbi.nlm.nih.gov/30639822Test

10

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

المصدر: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 24, iss 6

مصطلحات موضوعية: Myeloid, Aging, Transplantation Conditioning, Graft vs Host Disease, Disease, Regenerative Medicine, 0302 clinical medicine, Risk Factors, Stem Cell Research - Nonembryonic - Human, hemic and lymphatic diseases, 2.1 Biological and endogenous factors, Aetiology, Cancer, Pediatric, Leukemia, Incidence (epidemiology), Hazard ratio, Myeloid leukemia, Hematology, Middle Aged, Leukemia, Myeloid, Acute, surgical procedures, operative, Treatment Outcome, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Stem Cell Research - Nonembryonic - Non-Human, Stem cell, Post-transplant cyclophosphamide, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, Childhood Leukemia, Pediatric Cancer, Clinical Sciences, Immunology, Acute, Haploidentical, Article, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Humans, Aged, Transplantation, Acute myeloid leukemia, business.industry, Cytogenetics, Evaluation of treatments and therapeutic interventions, Stem Cell Research, Elderly patients, Orphan Drug, Myelodysplastic Syndromes, Transplantation, Haploidentical, business, Myelodysplastic syndrome, Haploidentical stem cell transplant, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746c0ff5788673bd945591073a317a73Test
https://escholarship.org/uc/item/7hr1p7nmTest

تنقيح النتائج